---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-057461"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T09:17:00.271463+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics appoints George Scangos to Board of Directors

## Summary
- George Scangos, Ph.D., appointed as Class I director effective May 9, 2023, serving until 2025 annual meeting.
- Scangos will serve on the Science and Technology Committee of the Board.
- Compensation includes $40,000 annual cash retainer and initial option for 44,000 shares vesting over 4 years.
- Scangos brings experience as former CEO of Biogen, Vir Biotechnology, and Exelixis.
- He will enter standard indemnification agreement with Voyager.

## SEC filing metadata
- accession: 0001104659-23-057461
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465923057461/0001104659-23-057461-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465923057461/tm2314979d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-057461
- JSON: https://secwatch.observer/filing/0001104659-23-057461.json
- Plain text: https://secwatch.observer/filing/0001104659-23-057461.txt

## Key facts
- Executive change
  George Scangos was appointed as director at Voyager Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: On May 6, 2023, the Board of Directors (the “Board”) of Voyager Therapeutics, Inc. (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed George Scangos, Ph.D. as a director of the Company and as a member of the Science and Technology Committee of the Board, effective May 9, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465923057461/0001104659-23-057461-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.